• Explore /
  • Poster
  • / Resistance to lorlatinib in <em>ROS1</em> fusion-positive non-small cell lung cancer.

Resistance to lorlatinib in ROS1 fusion-positive non-small cell lung cancer.

Abstract Poster

Authors

Jessica Lin

Jessica Jiyeong Lin

Massachusetts General Hospital, Boston, MA

Jessica Jiyeong Lin , Ted Johnson , Jochen K Lennerz , Charlotte Lee , Harper Grace Hubbeling , Beow Y. Yeap , Ibiayi Dagogo-Jack , Justin F. Gainor , Alice Tsang Shaw

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 38: 2020 (suppl; abstr 9611)

DOI

10.1200/JCO.2020.38.15_suppl.9611

Abstract #

9611

Poster Bd #

377

Abstract Disclosures

Similar Posters

First Author: Hongyun Zhao

Poster

2022 ASCO Annual Meeting

Treatment patterns and outcomes in <em>ALK</em> or <em>ROS1</em> altered NSCLC: An ATOMIC Registry Study.

Treatment patterns and outcomes in ALK or ROS1 altered NSCLC: An ATOMIC Registry Study.

First Author: Melina Elpi Marmarelis

First Author: Simon Baldacci

First Author: Jialei Wang